Local Literature Screening with DrugCard: Revolutionizing Pharmacovigilance

DrugCard is an AI-powered solution designed to streamline and enhance pharmacovigilance processes. It leverages the power of data intelligence to automate the screening of local medical journals, significantly reducing the time and resources required for this critical task. This allows pharma companies, CROs, and freelancers to focus on higher-value activities while ensuring full compliance with regulatory requirements.

Key Features and Benefits

• AI-driven automation: DrugCard automates the tedious process of manually reviewing medical journals, freeing up valuable time and resources.
• Multi-language support: The platform supports 100+ languages, enabling comprehensive screening of local medical literature worldwide.
• Global coverage: DrugCard covers 55+ countries and continuously monitors 1000+ local medical journals.
• Improved accuracy and completeness: AI-powered analysis ensures accurate and holistic data collection, reducing the risk of overlooking critical information.
• Enhanced traceability and transparency: DrugCard provides a complete audit trail of all activities, ensuring full transparency and compliance.
• Scalability: The platform is easily scalable to accommodate new markets and growing data volumes.
• Cost-effective: DrugCard offers a CAPEX-free investment, providing significant cost savings compared to traditional methods.
• Time savings: Users report up to a 70% reduction in time spent on literature screening.

Addressing the Challenges in Pharmacovigilance

The pharmacovigilance landscape is constantly evolving, presenting several challenges to companies:

• Increased competition: The emergence of AI-driven competitors is reshaping the industry.
• Rising costs: Investments in technology and personnel are increasing, while payback periods are lengthening.
• Regulatory pressure: The number of audits and non-compliance cases is on the rise.
• Staffing challenges: Recruiting and retaining qualified personnel is becoming increasingly difficult.
• Global pressures: New markets demand more sophisticated and efficient drug safety processes.

DrugCard directly addresses these challenges by providing a cost-effective, scalable, and accurate solution for local literature screening.

Use Cases

DrugCard is ideal for:

• CROs: Manage more PV projects and improve screening results, ensuring client satisfaction and regulatory compliance.
• MAHs: Gain a comprehensive overview of adverse events and ensure timely reporting.
• Freelancers: Increase efficiency and productivity, taking on more projects while maintaining high-quality work.

Testimonials

"Phenomenal tool that saves time and does local literature screening instead of you. The cost is minimal in comparison to the level of results it can give." — Valentina Eremenko, PV Freelancer

"DrugCard has helped our team put MLM process on autopilot. It is simple to use and frees up time for other tasks. I would highly recommend it to all PV services vendors." — Natalka Ischuk, Owner, PV Systems

"We need a solution for screening local literature from CIS countries. And your product is exactly what we need." — Vladyslav Vesna, Deputy QPPV, PV Team Leader, Farmak

Frequently Asked Questions

• How much time can I save when using DrugCard? Users report up to 70% time savings.
• Can DrugCard recognize poorly scanned texts? DrugCard is designed to handle various text formats, including those with imperfections.
• Can DrugCard screen local medical journals in local languages? Yes, DrugCard supports 100+ languages.
• Can I have weekly reports with all data collected in a week? Yes, DrugCard provides customizable reporting options.
• How long does it take to add journals in a new country? The process is streamlined and efficient.
• How long could it take for me to develop such a system internally? Developing a comparable system internally would be a significant undertaking.
• With DrugCard can I manage local medical literature screening without any staff? DrugCard significantly reduces the need for manual review, but human oversight is still recommended.
• What are your unique strengths compared to your competition? DrugCard's combination of AI-powered automation, multi-language support, and global coverage sets it apart.

Conclusion

DrugCard is transforming pharmacovigilance by providing an efficient, accurate, and cost-effective solution for local literature screening. By leveraging the power of AI, DrugCard empowers professionals to focus on strategic initiatives while ensuring full compliance and delivering exceptional results.